LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
PLOS Biology · 2023
DOI: 10.1371/journal.pbio.3001959 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2023. Verfasst von Jarrod Shilts und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Department of Health.
Abstract (Originalsprache)
The interactions between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and human host factors enable the virus to propagate infections that lead to Coronavirus Disease 2019 (COVID-19). The spike protein is the largest structural component of the virus and mediates interactions essential for infection, including with the primary angiotensin-converting enzyme 2 (ACE2) receptor. We performed two independent cell-based systematic screens to determine whether there are additional proteins by which the spike protein of SARS-CoV-2 can interact with human cells. We discovered that in addition to ACE2, expression of LRRC15 also causes spike protein binding. This interaction is distinct from other known spike attachment mechanisms such as heparan sulfates or lectin receptors. Measurements of orthologous coronavirus spike proteins implied the interaction was functionally restricted to SARS-CoV-2 by accessibility. We localized the interaction to the C-terminus of the S1 domain and showed that LRRC15 shares recognition of the ACE2 receptor binding domain. From analyzing proteomics and single-cell transcriptomics, we identify LRRC15 expression as being common in human lung vasculature cells and fibroblasts. Levels of LRRC15 were greatly elevated by inflammatory signals in the lungs of COVID-19 patients. Although infection assays demonstrated that LRRC15 alone is not sufficient to permit viral entry, we present evidence that it can modulate infection of human cells. This unexpected interaction merits further investigation to determine how SARS-CoV-2 exploits host LRRC15 and whether it could account for any of the distinctive features of COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Cambridge, United Kingdom.
- Department of Biology, Hull York Medical School, York Biomedical Research Institute, University of York, York, United Kingdom.
- Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom.
- Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany.
- Faculty of Biology and Psychology, Georg-August University Göttingen, Göttingen, Germany.
- NHS Blood and Transplant, Cambridge, United Kingdom.
ORCID-Profile: Jarrod Shilts, Thomas W M Crozier, Ana Teixeira-Silva, Edward J D Greenwood, Christian M Gawden-Bone, Tekle Pauzaite, Markus Hoffmann, James A Nathan, Stefan Pöhlmann, Paul J Lehner, Gavin J Wright
Förderung
- Medical Research Council
- Wellcome Trust
- Department of Health
- Pfizer UK
- National Institute for Health Research
- Addenbrooke’s Charitable Trust, Cambridge University Hospitals
- NHS Blood and Transplant
- NIHR Cambridge Biomedical Research Centre
Zitieren
APA
Shilts, J., Crozier, T. W. M., Teixeira-Silva, A., Gabaev, I., Gerber, P. P., Greenwood, E. J. D., Watson, S. J., Ortmann, B. M., Gawden-Bone, C. M., Pauzaite, T., Hoffmann, M., Nathan, J. A., Pöhlmann, S., Matheson, N. J., Lehner, P. J., & Wright, G. J. (2023). LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein. PLOS Biology. https://doi.org/10.1371/journal.pbio.3001959
Vancouver
Shilts J, Crozier TWM, Teixeira-Silva A, Gabaev I, Gerber PP, Greenwood EJD, et al. LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein. PLOS Biology. 2023. doi:10.1371/journal.pbio.3001959
BibTeX
@article{Shilts2023,
author = {Shilts, Jarrod and Crozier, Thomas W M and Teixeira-Silva, Ana and Gabaev, Ildar and Gerber, Pehuén Pereyra and Greenwood, Edward J D and Watson, Samuel James and Ortmann, Brian M and Gawden-Bone, Christian M and Pauzaite, Tekle and Hoffmann, Markus and Nathan, James A and Pöhlmann, Stefan and Matheson, Nicholas J and Lehner, Paul J and Wright, Gavin J},
title = {LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein},
journal = {PLOS Biology},
year = {2023},
doi = {10.1371/journal.pbio.3001959}
}
EUVIMED